• 1
    Cristofanilli M,Budd GT,Ellis MJ,Stopeck A,Matera J,Miller MC,Rueben JM Doyle G,Allard WJ,Terstappen LWMM,Hayes DF. Circulating tumor cells. Disease progression and survival in metastatic breast cancer. N Engl J Med 2004; 351: 781791.
  • 2
    Cristofanilli M,Hayes DF,Budd GT,Ellis MJ,Stopeck AT,Doyle GV,Matera J,Allard WJ,Miller MC,Rueben JM,Fritsche HA,Hortobagyi GN,Terstappen LWMM. Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 2005; 23: 14201430.
  • 3
    Budd G,Cristofanilli M,Ellis M,Stopeck A,Borden E,Miller MC,Matera J,Repollet M,Doyle G,Terstappen LWMM,Hayes D. Circulating tumor cells versus imaging—Predicting overall survival in metastatic breast cancer. Clin Can Res 2006; 12: 64046409.
  • 4
    Hayes DF,Cristofanilli M,Budd GT,Ellis MJ,Stopeck A,Miller MC,Matera J,Allard JW,Doyle GV,Terstappen LWMM. Circulating tumor cells predict progression free and overall survival at each follow-up time point during therapy of metastatic breast cancer patients. Clin Cancer Res 2006; 12: 42184224.
  • 5
    Cohen SJ,Punt CJA,Iannotti N,Saidman BH,Sabbath KD,Gabrail NY,Picus J,Morse M,Mitchell E,Desch CE,Miller MC,Doyle GV,Tissing H,Terstappen LWMM,Meropol NJ. The relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 2008; 26: 32133221.
  • 6
    DeBono JS,Scher HI,Montgomery RB,Parker C,Miller MC,Tissing H,Doyle GV,Terstappen LWWM,Pienta KJ,Raghavan D. Circulating Tumor Cells (CTC) predict survival benefit from treatment in metastatic castration resistant prostate cancer (CRPC). Clin Cancer Res 2008; 14: 63026309.
  • 7
    Kagan M,Howard D,Bendele T,Mayes J,Silvia J,Repollet M,Doyle J,Allard J,Tu N,Bui T,Russell T,Rao C,Hermann M,Rutner H,Terstappen LWMM. A sample preparation and analysis system for identification of circulating tumor cells. J Clin Lig Assay 2002; 25: 104110.
  • 8
    Kagan M,Howard D,Bendele T,Rao C,Terstappen LWMM. Circulating tumor cells as cancer markers, a sample preparation and analysis system. In: DiamandisEP,FritscheHA,LiljaH,ChanDW,SchwartzM, editors. Tumor Markers: Physiology, Pathobiology, Technology and Clinical Applications. Washington: AACC Press; 2002. pp 495498.
  • 9
    Allard WJ,Matera J,Miller MC,Repollet M,Connelly MC,Rao C,Tibbe A,Uhr JW,Terstappen LWMM. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with non-malignant diseases. Clin Can Res 2004; 10: 68976904.
  • 10
    Hayes DF,Walker TM,Singh B,Vitetta ES,Uhr JW,Gross S,Rao C,Doyle GV,Terstappen LWMM. Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer. Int J Oncol 2002; 21: 11111118.
  • 11
    Meng S,Tripathy D,Shete S,Ashfaq R,Haley B,Perkins S,Beitsch P,Khan A,Euhus D,Osborne C,Frenkel E,Hoover S,Leitch M,Clifford E,Morrison L,Herlyn D,Terstappen LWMM,Fleming T,Fehm T,Tucker T,Lane N,Wang J,Uhr J. HER-2 gene amplification can be acquired as breast cancer progresses. PNAS 2004; 101: 93939398.
  • 12
    Meng S,Tripathy D,Frenkel EP,Shete S,Naftalis EZ,Huth JF,Beitsch PD,Leitch M,Hoover S,Euhus D,Haley B,Morrison L,Fleming TP,Herylyn D,Terstappen LWMM,Fehm T,Tucker TF,Lane N,Uhr JW. Circulating tumor cells in patients with breast cancer dormancy. Clin Can Res 2004; 10: 81528162.
  • 13
    Meng S,Tripathy D,Frenkel EP,Shete S,Ashfaq R,Saboorian H,Haley B,Frenkel E,Euhus D,Leitch M,Osborne C,Clifford E,Perkins S,Beitsch P,Kahn A,Morrison L,Herylyn D,Terstappen LWMM,Lane N,Wang J,Uhr JW. uPar and Her-2 gene status in individual breast cancer cells from blood and tissues. PNAS 2006; 103: 1736117365.
  • 14
    Shaffer DR,Leversha MA,Danila DC,Lin O,Gonzalez-Espinoza R,Gu B,Anand A,Han J,Smith K,Maslak P,Lilja H,Doyle G,Terstappan LWMM,Heller G,Fleisher M,Scher HI. Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer. Clin Cancer Res 2007; 13: 20232029.
  • 15
    de Bono JS,Attard G,Adjei A,Pollak MN,Fong PC,Haluska P,Roberts L,Melvin C,Repollet M,Chianese D,Connely M,Terstappen LWMM,Gualberto A. Potential applications for circulating tumor cells expressing the insulin growth factor-I receptor. Clin Can Res 2007; 13: 36113616.
  • 16
    Tibbe AGJ,Miller C,Terstappen LWMM. Statistical considerations for enumeration of circulating tumor cells. Cytometry Part A 2007; 71A: 154162.
  • 17
    Terstappen LWMM,Dolan GJ. Magnetic separation apparatus and methods. U.S. Patent 6,660,159 B1, December 9, 2003
  • 18
    Tibbe AGJ,de Grooth BG,Greve J,Dolan GJ,Rao C,Terstappen LWMM. Magnetic field design for selecting and aligning immunomagnetic labeled cells. Cytometry Part A 2002; 47A: 163172.
  • 19
    Recamier JCA. L'histoire de le Meme Maladie. 1829; Gabor vol: 110.
  • 20
    Ashworth TR. A case of cancer in which cells similar to those in the tumours were seen in the blood after death. Australian Med J 1869; 14: 146147.
  • 21
    Engell HC. Cancer cells in the circulating blood; a clinical study on the occurrence of cancer cells in the peripheral blood and in venous blood draining the tumour area at operation. Acta Chir Scand Suppl 1955; 201: 170.
  • 22
    Carey RW,Taft PD,Bennett JM,Kaufman S. Carcinocythemia (carcinoma cell leukemia). An acute leukemia-like picture due to metastatic carcinoma cells. Am J Med 1976; 60: 273278.
  • 23
    Myerowitz RL,Edwards PA,Sartiano GP. Carcinocythemia (carcinoma cell leukemia) due to metastatic carcinoma of the breast: Report of a case. Cancer 1977; 40: 31073111.
  • 24
    Gallivan MV,Lokich JJ. Carcinocythemia (carcinoma cell leukemia). Report of two cases with English literature review. Cancer 1984; 53: 11001102.
  • 25
    Sile CC,Perry DJ,Nam L. Small cell carcinocythemia. Arch Pathol Lab Med 1999; 123: 426428.
  • 26
    Seronie-Vivien S,Mery E,Delord JP,Fillola G,Tkaczuk J,Voigt JJ,Bugat R. Carcinocythemia as the single extension of breast cancer: Report of a case and review of the literature. Ann Oncol 2001; 12: 10191022.
  • 27
    Yam LT,Janckila AJ. Immunocytodiagnosis of carcinocythemia in disseminated breast cancer. Acta Cytol 1987; 31: 6872.
  • 28
    Ross JS,Gray GS. Targeted therapy for cancer: The HER-2/neu and Herceptin story. Clin Leadership Manag Rev 2003; 17: 333340.
  • 29
    Vogelstein B,Fearon ER,Hamilton SR,Kern SE,Preisinger AC,Leppert M,Nakamura Y,White R,Smits AM,Bos JL. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525532.
  • 30
    Ingvarsson S. Molecular genetics of breast cancer progression. Semin Cancer Biol 1999; 9: 277288.
  • 31
    Pihan GA.Purohit A.Wallace J.Malhotra R.Liotta A.Doxsey SJ. Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. Cancer Res 2001; 61: 22122219.
  • 32
    Kleer CG,Bryant BR,Glordano TJ,Sobel M,Merino MJ. Genetic changes in chromosomes 1p and 17p in thyroid cancer progression. Endocr Pathol 2000; 11: 137143.
  • 33
    Alers JC,Rochat J,Krijtenburg PJ,Hop WCJ,Kranse R.Rosenberg C.Tanke HJ,Schroder FH,van Deken H. Identification of genetic markers of prostatic cancer progression. Lab Invest 2000; 80: 931942.
  • 34
    Endo C,Sagawa N,Sato N,Chen YSakurada A,Aikawa H,Takahashi S,Usuda K,Saito Y,Fujimura S. Sequential loss of heterozygosity in the progression of squamous cell carcinoma of the lung. Br J Cancer 1998; 78: 612615.
  • 35
    Simon R,Nocito A,Hubscher T,Bucher C,Torhorst J,Schraml P,Bubendorf L,Mihatsch MM,Moch H,Wilber K,Schotzau A,Kononen J,Sauter G. Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer. J Natl Cancer Inst 2001; 93: 11411146.
  • 36
    Larson CJ,Moreno JG,Pienta KJ,Gross S,Repollet M,O'Hara SM,Russell T,Terstappen LWMM. Apoptosis of circulating tumor cells in prostate cancer patients. Cytometry Part A 2004; 62A: 4653.
  • 37
    Wang ZP,Eisenberger MA,Carducci MA,Partin AW,Scher HI,Tso PO. Identification and characterization of circulating prostate carcinoma cells. Cancer 2000; 88: 27872795.
  • 38
    Racila E,Euhus D,Weiss AJ,Rao C,McConnell J,Terstappen LWMM,Uhr JW. Detection and characterization of carcinoma cells in the blood. PNAS 1998; 95: 45894594.
  • 39
    Adams AA,Okagbare PI,Feng J,Hupert ML,Patterson D,Göttert J,McCarley RL,Nikitopoulos D,Murphy MC,Soper SA. Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor. J Am Chem Soc 2008; 130: 86338641.
  • 40
    Campos M,Prior C,Warleta F,Zudaire I,Ruíz-Mora J,Catena R,Calvo A,Gaforio JJ. Phenotypic and genetic characterization of circulating tumor cells by combining immunomagnetic selection and fiction techniques. J Histochem Cytochem 2008; 56: 667675.
  • 41
    Pachmann K,Camara O,Kavallaris A,Krauspe S,Malarski N,Gajda M,Kroll T,Jörke C,Hammer U,Altendorf-Hofmann A,Rabenstein C,Pachmann U,Runnebaum I,Höffken K. Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. J Clin Oncol 2008; 10:26: 12081215.
  • 42
    Schindlbeck C,Stellwagen J,Jeschke U,Karsten U,Rack B,Janni W,Jückstock J,Tulusan A,Sommer H,Friese K. Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen. Clin Exp Metastasis. 2008; 25: 233240.
  • 43
    Nagrath S,Sequist LV,Maheswaran S,Bell DW,Irimia D,Ulkus L,Smith MR,Kwak EL,Digumarthy S,Muzikansky A,Ryan P,Balis UJ,Tompkins RG,Haber DA,Toner M. Isolation of rare circulating tumour cells in cancer patients by microchip technology 2007; 450: 12351239.
  • 44
    Roeser T,Ritzi M,Drese KS,Laureyn W,Liu C,O'Sullivan CK,Ozalp VC,Fermer C,Nilsson O,Hauch S,Albert W,Borgen E,Nygre AO. Lab-on-chip for the isolation and characterization of circulating tumor cells. Conf Proc IEEE Eng Med Biol Soc 2007; 64476449.
  • 45
    Zheng S,Lin H,Liu JQ,Balic M,Datar R,Cote RJ,Tai YC. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J Chromatogr A 2007; 1162: 154161.
  • 46
    Tveito S,Maelandsmo GM,Hoifodt HK,Rasmussen H,Fodstad O. Specific isolation of disseminated cancer cells: a new method permitting sensitive detection of target molecules of diagnostic and therapeutic value. Clin Exp Metastasis 2007; 24: 317327.
  • 47
    Fehm T,Sagalowsky A,Clifford E,Beitsch P,Saboorian H,Euhus D,Meng S,Morrison L,Tucker T,Lane N,Ghadimi BM,Heselmeyer-Haddad K,Ried T,Rao C,Uhr J. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res 2002; 8: 20732084.